P

Inventor

GUBA WOLFGANG

DE49 patents
⚠️ This page may combine multiple inventors who share the name “GUBA WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

40 patents
US8618296B2Dec 31, 2013

Arylethynyl derivatives

HOFFMANN LA ROCHE4 citations74
US8513273B2Aug 20, 2013

Arylethynyl derivatives

HOFFMANN LA ROCHE4 citations74
US10723729B2Jul 28, 2020

BACE1 inhibitors

HOFFMANN LA ROCHE1 citations73
US10399969B2Sep 3, 2019

BACE1 inhibitors

HOFFMANN LA ROCHE2 citations73
US10047081B2Aug 14, 2018

BACE1 inhibitors

HOFFMANN LA ROCHE3 citations73
US9695128B2Jul 4, 2017

Ethynyl derivatives

HOFFMANN LA ROCHE4 citations73
US8716316B2May 6, 2014

Positive allosteric modulators (PAM)

HOFFMANN LA ROCHE4 citations73
US10414780B2Sep 17, 2019

Pyridyl-triazabicycles

HOFFMANN LA ROCHE4 citations72
US10246468B2Apr 2, 2019

BACE1 inhibitors

HOFFMANN LA ROCHE3 citations72
US10189848B2Jan 29, 2019

Ethynyl derivatives

HOFFMANN LA ROCHE4 citations72
US10065956B2Sep 4, 2018

Ethynyl derivatives

HOFFMANN LA ROCHE4 citations72
US10047102B2Aug 14, 2018

Pyridyl-triazabicycles

HOFFMANN LA ROCHE4 citations72
US9725416B2Aug 8, 2017

Ethynyl derivatives

HOFFMANN LA ROCHE4 citations72
US9540397B2Jan 10, 2017

BACE1 inhibitors

HOFFMANN LA ROCHE2 citations71
US6900227B2May 31, 2005

Benzodioxole derivatives

HOFFMANN LA ROCHE7 citations71
US9315498B2Apr 19, 2016

Arlethynyl derivatives

HOFFMANN LA ROCHE2 citations63
US7253197B2Aug 7, 2007

Aminothiazole derivatives

HOFFMANN LA ROCHE5 citations63
US12006323B2Jun 11, 2024

Ethynyl derivatives

HOFFMANN LA ROCHE0 citations62
US11034687B2Jun 15, 2021

BACE1 inhibitors

HOFFMANN LA ROCHE0 citations62
US11034699B2Jun 15, 2021

Ethynyl derivatives

HOFFMANN LA ROCHE0 citations62
US7576088B2Aug 18, 2009

Benzodioxole derivatives

HOFFMANN LA ROCHE2 citations60
US12421209B2Sep 23, 2025

Compounds

HOFFMANN LA ROCHE0 citations54
US12509467B2Dec 30, 2025

CGAS inhibiting triazolopyrimidone derivatives

HOFFMANN LA ROCHE0 citations52
US8933094B2Jan 13, 2015

Ethynyl compounds useful for treatment of CNS disorder

HOFFMANN LA ROCHE0 citations52
US10829500B2Nov 10, 2020

Pyridyl-triazabicycles

HOFFMANN LA ROCHE0 citations51
US10696691B2Jun 30, 2020

BACE1 inhibitors

HOFFMANN LA ROCHE0 citations51
US9920072B2Mar 20, 2018

BACE1 inhibitors

HOFFMANN LA ROCHE1 citations51
US7135488B2Nov 14, 2006

Pyrrolyl-thiazole derivatives

HOFFMANN LA ROCHE2 citations51
US10457686B2Oct 29, 2019

[1,2,3]triazolo[4,5-D]pyrimidine derivatives

HOFFMANN LA ROCHE0 citations50
US10450321B2Oct 22, 2019

[1,2,3]triazolo[4,5-D]pyrimidine derivatives

HOFFMANN LA ROCHE0 citations48
US7323466B2Jan 29, 2008

Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity

HOFFMANN LA ROCHE1 citations48
US11655243B2May 23, 2023

Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists

HOFFMANN LA ROCHE0 citations46
US7645753B2Jan 12, 2010

Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives

HOFFMANN LA ROCHE1 citations46
US9676732B2Jun 13, 2017

Ethynyl derivatives

HOFFMANN LA ROCHE0 citations41
US9605006B2Mar 28, 2017

5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines

HOFFMANN LA ROCHE0 citations40
US10457684B2Oct 29, 2019

[1,2,3]triazolo[4,5-d]pyrimidine derivatives

HOFFMANN LA ROCHE0 citations39
US10457685B2Oct 29, 2019

[1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor

HOFFMANN LA ROCHE0 citations38
US9896438B2Feb 20, 2018

2,2,2-trifluoroethyl-thiadiazines

HOFFMANN LA ROCHE0 citations38
US7772253B2Aug 10, 2010

Amide derivatives as somatostatin receptor 5 antagonists

HOFFMANN LA ROCHE0 citations37
US7989449B2Aug 2, 2011

4,5-dihydro-oxazol-2-yl amine derivatives

HOFFMANN LA ROCHE0 citations36

GREEN LUKE

3 patents

BANNER DAVID

3 patents

ANDREINI MATTEO

2 patents

GABELLIERI EMANUELE

1 patent